These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10030523)

  • 21. Drug information reaching more patients, FDA data show.
    Am J Health Syst Pharm; 1998 Jan; 55(2):107-8, 110. PubMed ID: 9527436
    [No Abstract]   [Full Text] [Related]  

  • 22. The product label: how pharmacokinetics and pharmacodynamics reach the prescriber.
    Marroum PJ; Gobburu J
    Clin Pharmacokinet; 2002; 41(3):161-9. PubMed ID: 11929317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Over-the-counter human drugs; labeling requirements. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(51):13254-303. PubMed ID: 10557606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients.
    Green DJ; Mummaneni P; Kim IW; Oh JM; Pacanowski M; Burckart GJ
    Clin Pharmacol Ther; 2016 Jun; 99(6):622-32. PubMed ID: 26693845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From off-label prescribing towards a new FDA.
    Tabarrok A
    Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of drugs for unlabeled indications.
    Nightingale SL
    Am Fam Physician; 1986 Sep; 34(3):269. PubMed ID: 3751849
    [No Abstract]   [Full Text] [Related]  

  • 29. Medication use during pregnancy and lactation: the new FDA drug labeling.
    Tillett J
    J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
    [No Abstract]   [Full Text] [Related]  

  • 30. US FDA calls for technological attack on drug counterfeiting.
    Ault A
    Lancet; 2004 Feb; 363(9410):714. PubMed ID: 15005089
    [No Abstract]   [Full Text] [Related]  

  • 31. Legal considerations in off-label medication prescribing.
    Blum RS
    Arch Intern Med; 2002 Aug 12-26; 162(15):1777-9. PubMed ID: 12153383
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA labeling status of pediatric medications.
    Yoon EY; Davis MM; El-Essawi H; Cabana MD
    Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220
    [No Abstract]   [Full Text] [Related]  

  • 33. The patient package insert--health care provider's friend or foe?
    Hirsh HL
    Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734
    [No Abstract]   [Full Text] [Related]  

  • 34. Should expiration dates be required on patients' prescription labels?
    Hadeler F
    Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
    [No Abstract]   [Full Text] [Related]  

  • 35. Rx package inserts: redesigned with fewer errors in mind.
    Fass JA; Seamon MJ; Cytacki J
    J Fam Pract; 2007 Jun; 56(6):438-41. PubMed ID: 17543253
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug labeling and promotion: evolution and application of regulatory policy.
    Hayes TA
    Food Drug Law J; 1996; 51(1):57-73. PubMed ID: 11794353
    [No Abstract]   [Full Text] [Related]  

  • 37. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
    Willig SH
    Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
    [No Abstract]   [Full Text] [Related]  

  • 38. Sunscreen drug products for over-the-counter human use; final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 May; 64(98):27666-93. PubMed ID: 10558542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical inserts: legal consequences.
    Hirsh HL
    Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulating off-label drug use--rethinking the role of the FDA.
    Stafford RS
    N Engl J Med; 2008 Apr; 358(14):1427-9. PubMed ID: 18385495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.